CTRI/2021/10/037309尚未招募3 期
A PHASE III, PROSPECTIVE, RANDOMIZED, MULTICENTRIC, MULTIDOSE, TWO TREATMENT, PARALLEL, COMPARATIVE CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PINAK TABLET AGAINST CORONA VIRUSES ADMINISTERED ORALLY AS ADJUVANT TO ART IN HUMAN ADULT PATIENTS WITH AIDS, HEPATITIS B AND HEPATITIS C
Sudesh Shiva Devadiga0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Diagnosed Patients of AIDS
- •Diagnosed Patients of Hepatitis B
- •Diagnosed Patients of Hepatitis C
- •Subjects voluntarily providing written informed consent and willing to give regular follow-up
排除标准
- •Following death prone toxic cases will be excluded
- •Subjects with life expectancy less than 1 year
- •Associated serious diseases
- •Patients in ICU
- •Patients with ventilator
- •Patients with renal failure
- •All pediatrics cases
- •All pregnant cases
- •All lactating cases
- •LFT more than 3 times upper limit of normal
- •Hypersensitivity to any of the ingredients of study product
研究者
相似试验
已完成
3 期
A Study to Determine the Effect of Aztreonam-Avibactam Versus Meropenem for the Treatment of Serious Infections Due to Gram Negative Bacteria.CTRI/2018/09/015762Pfizer Limited27
尚未招募
不适用
REVISIT-A048 Other specified bacterial intestinal infections-J168 Pneumonia due to other specified infectious organismsOther specified bacterial intestinal infectionsPneumonia due to other specified infectious organismsA048J168PER-014-18Pfizer Inc.,
进行中（未招募）
不适用
A PHASE III, RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO ANDCYCLOSPORINE CONTROLLED STUDY OF ISA247 IN PLAQUE PSORIASISPATIENTS (ISA05-25) - None availableEUCTR2006-001352-13-DEIsotechnika Inc900
已完成
不适用
A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLEDSTUDY TO DETERMINE THE EFFICACY OF ADJUVANT DURVALUMAB IN COMBINATIONWITH PLATINUM-BASED CHEMOTHERAPY IN COMPLETELY RESECTED STAGE II-IIINSCLC (MERMAID-1)PER-043-20AstraZeneca AB,
进行中（未招募）
1 期
A Phase 3 Clinical Trial of Omalizumab for Chronic Rhinosinusitus with Nasal PolypsEUCTR2017-001718-28-BEF. Hoffmann-La Roche Ltd120